Company Filing History:
1 out of 832,961 Years Active: 2016
Title: Heidrun Gehlen: Innovator in Immunomodulating Nanoparticulate Composition
Introduction
Heidrun Gehlen is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical compositions, particularly in the area of immunomodulation. Her innovative work focuses on developing solutions for allergic and inflammatory diseases affecting the lower airways in mammals.
Latest Patents
Heidrun Gehlen holds a patent for an immunomodulating nanoparticulate composition. This invention relates to a nebulizable pharmaceutical composition that includes a pharmaceutically acceptable protein-based nanocarrier, preferably sized between 150 to 300 nm. The composition is designed to deliver a preventative or therapeutic amount of an active agent, specifically targeting allergic and inflammatory diseases of the lower airways. The active agent is preferably a CpG oligodeoxynucleotide (CpG-ODN), and the composition is noted for its prolonged clinical effect.
Career Highlights
Throughout her career, Heidrun Gehlen has worked with various organizations, contributing her expertise in pharmaceutical innovations. Her work has been instrumental in advancing the understanding and treatment of respiratory conditions.
Collaborations
Heidrun has collaborated with notable professionals in her field, including Sebastian Fuchs and Conrad Coester. These collaborations have further enriched her research and development efforts.
Conclusion
Heidrun Gehlen's contributions to immunomodulating nanoparticulate compositions highlight her role as a leading inventor in the pharmaceutical industry. Her innovative approaches continue to pave the way for advancements in treating allergic and inflammatory diseases.